4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-011432
Director sold 4,497 shares at an average $60.37 ($271,467)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Henderson Jeffrey William Director | 2025-04-28 | Sale 10b5-1 | −4,297 | $60.34 | $259,268 | 28,811 | D |
| Henderson Jeffrey William Director | 2025-04-28 | Sale 10b5-1 | −200 | $61.00 | $12,199 | 28,611 | D |
| Open-market sales · 4,497 sh · avg $60.37 · $271,467 | |||||||
Loading xslF345X05/form4-04282025_100414.xml…